Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of central nervous system agents. Its cyclobutane core substituted with a hydroxyl group at position 3, a carboxylic acid at position 1, and a 3-methoxyphenyl group at position 1 supports the creation of bioactive molecules. These functional groups allow for further chemical modifications, enabling the design of analogs with potential analgesic or neuromodulatory activity. Commonly employed in research settings and medicinal chemistry for structure-activity relationship (SAR) studies involving cyclobutane-based scaffolds.